Plain-English translation of NCT06892275 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a decision-support tool — a simple guide to help you understand your breast cancer risk and breast MRI screening options — helps women make choices that feel right for them. Researchers want to see if the tool leads to more informed decisions compared to standard care alone.
Many women at high risk for breast cancer don't have enough information to decide whether breast MRI screening is right for them. This study aims to test whether a clear, personalized decision guide can help women understand their options better and feel more confident about their choice.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups. Both groups will receive a letter with your breast cancer risk level and information about breast MRI screening, plus a way to contact a nurse practitioner with questions. One group will also receive a decision-support guide by mail or email to help you think through whether breast MRI is right for you. You'll complete surveys to share your thoughts about the information and your decision.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Sponsor
Georgetown University
Enrollment target
~80 participants
Started
June 2025
Primary completion
June 2027
Age range
18 Years – 74 Years
Sex
Female only
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Claire C. Conley, PhD
Georgetown University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.